The Ganglioside GD1b Antibody IgG Test is a specialized blood test designed to detect the presence of IgG antibodies against ganglioside GD1b in the bloodstream. Gangliosides are complex glycosphingolipids that play critical roles in cell-to-cell communication and are abundant in the nervous system. The presence of antibodies against ganglioside GD1b can be associated with various neurological disorders, including Guillain-Barré syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), and other neuropathies.
This test is crucial for diagnosing and managing patients with suspected autoimmune neuropathies. By identifying the specific antibodies, healthcare providers can better understand the nature of the neuropathy, leading to more targeted and effective treatment plans.
In the United Arab Emirates, this test is available at DNA Labs UAE, a leading diagnostic center known for its comprehensive range of tests and advanced laboratory technologies. The cost of the Ganglioside GD1b Antibody IgG Test at DNA Labs UAE is 1420 AED. Patients or healthcare providers looking to conduct this test can expect state-of-the-art facilities and professional services, ensuring accurate and reliable results.
The C6 Complement Test is a specialized diagnostic procedure designed to measure the levels of the C6 protein in the blood. C6 is a crucial component of the complement system, which plays a vital role in the immune system by helping to clear pathogens from the body. Abnormal levels of C6 can indicate issues with the complement system, which may be related to a variety of conditions, including autoimmune diseases, recurrent bacterial infections, and certain types of kidney diseases.
The test involves drawing a blood sample from the patient, which is then analyzed in a laboratory to determine the concentration of C6 protein. It is a valuable tool for clinicians in diagnosing and managing conditions related to the complement system.
In the United Arab Emirates, the C6 Complement Test can be conducted at DNA Labs UAE, a leading facility known for its state-of-the-art testing services. The cost of the test at DNA Labs UAE is 1420 AED. This facility is equipped with advanced diagnostic technologies and staffed by experienced professionals, ensuring accurate and reliable test results. Patients choosing DNA Labs UAE for their C6 Complement Test can expect a high standard of service and care throughout the testing process.
The Infliximab Antibody Test is a crucial diagnostic tool used to monitor patients undergoing treatment with infliximab, a therapeutic antibody commonly prescribed for autoimmune diseases such as rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, and ankylosing spondylitis. This test measures the levels of infliximab in the blood to assess the effectiveness of the treatment and the presence of antibodies against infliximab, which can reduce its efficacy or lead to adverse reactions.
Conducted at DNA Labs UAE, a leading facility known for its advanced diagnostic services, the Infliximab Antibody Test ensures precise monitoring and management of patients' treatment plans. The test is priced at 1410 AED, reflecting the sophisticated technology and expertise involved in its execution. By offering this test, DNA Labs UAE supports healthcare providers in optimizing treatment strategies for patients on infliximab therapy, ensuring better health outcomes and personalized care.
The BCR-ABL Quantitative MRD (Minimal Residual Disease) Monitor Test is a sophisticated diagnostic procedure employed to measure the amount of BCR-ABL fusion gene transcripts present in the blood or bone marrow of patients who have been diagnosed with chronic myeloid leukemia (CML) or acute lymphoblastic leukemia (ALL). This test is crucial for evaluating the effectiveness of therapy, predicting relapse, and guiding treatment decisions in individuals undergoing treatment for these types of leukemia.
Performed at DNA Labs UAE, a leading diagnostic facility, the test leverages advanced molecular techniques to provide accurate and sensitive detection of minimal residual disease, offering valuable insights into the patient's response to treatment and disease progression. The cost of the BCR-ABL Quantitative MRD Monitor Test at DNA Labs UAE is set at 1400 AED, reflecting the comprehensive approach and cutting-edge technology utilized in this critical assessment. This test plays a pivotal role in personalized medicine, enabling healthcare providers to tailor treatment strategies based on the patient's specific disease dynamics and response to therapy.
The Cytochrome P450 2C19 Genotyping (CYP2C19) Clopidogrel Resistance 23410 Test is a specialized diagnostic examination available at DNA Labs UAE, designed to identify genetic variations in the CYP2C19 gene. These genetic differences can significantly affect how an individual metabolizes certain medications, including clopidogrel, a commonly prescribed antiplatelet drug used to prevent blood clots. The test's primary aim is to detect specific genetic markers associated with reduced enzyme activity, which can lead to clopidogrel resistance, potentially increasing the risk of cardiovascular events in patients.
Understanding an individual's CYP2C19 genotype is crucial for healthcare providers to tailor medication choices and dosages for optimal efficacy and safety, particularly in patients undergoing treatments for conditions like coronary artery disease, stroke, and other thrombotic disorders. The test, priced at 1200 AED, involves a simple genetic analysis, usually through a blood sample, and provides valuable insights that can guide personalized treatment plans, enhancing patient outcomes and minimizing adverse drug reactions. DNA Labs UAE, a leading provider of genetic testing services, offers this advanced diagnostic tool as part of its comprehensive portfolio to support personalized medicine and improve patient care.
The Factor II Mutation Screening F2 - G20210A Test is a specialized genetic test offered by DNA Labs UAE, designed to identify the presence of the G20210A mutation in the F2 gene. This mutation is associated with an increased risk of developing blood clots, including conditions such as deep vein thrombosis (DVT) and pulmonary embolism (PE), which can have serious health implications. By detecting this mutation, individuals can take preventive measures or seek early treatment to manage their risk effectively.
The test is conducted through a simple blood sample, utilizing advanced genetic analysis techniques to accurately identify the presence of the G20210A mutation. The cost of the test is set at 1200 AED, making it accessible for individuals who are at risk or have a family history of blood clotting disorders. DNA Labs UAE is known for its reliable and accurate genetic testing services, providing patients and healthcare providers with crucial information for managing health and preventing complications associated with the Factor II mutation.
The Factor V Mutation Screening F5 - G1691A Test, commonly referred to as the Factor V Leiden test, is a genetic test performed to detect the G1691A mutation in the F5 gene. This mutation is a well-known risk factor for developing abnormal blood clots, which can lead to conditions such as deep vein thrombosis (DVT) and pulmonary embolism (PE). The presence of the Factor V Leiden mutation makes an individual more prone to clotting disorders, hence, identifying it is crucial for managing and preventing complications.
The test is offered at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the test is 1200 AED, making it accessible for those who need to ascertain their genetic risk for clotting disorders. Testing involves a simple blood draw, and results are typically provided within a specified timeframe, offering individuals valuable insights into their genetic health and enabling them to take proactive steps in consultation with healthcare professionals.
The FLT3 ITD D835Y Mutation Detection Test is a specialized diagnostic procedure designed to identify specific mutations within the FLT3 gene, namely the internal tandem duplication (ITD) and the D835Y point mutation. These mutations are significant because they are often found in patients with acute myeloid leukemia (AML), and their presence can influence treatment choices and prognostic outlooks. The test utilizes advanced molecular techniques to analyze the FLT3 gene from a patient's blood or bone marrow sample, ensuring accurate detection of these mutations.
The cost of the FLT3 ITD D835Y Mutation Detection Test is set at 1200 AED. It is performed at DNA Labs UAE, a facility renowned for its state-of-the-art genetic testing services. This lab employs cutting-edge technology and highly qualified professionals to provide reliable and precise test results, aiding in the effective management and treatment planning for patients with AML.
The "Frozen-2 Test" is a specialized diagnostic procedure available at DNA Labs UAE, designed to provide comprehensive insights into specific health markers or conditions. Priced at 1200 AED, this test utilizes advanced genetic analysis techniques to examine DNA samples, offering detailed results that can aid in understanding genetic predispositions, potential health risks, or the effectiveness of certain treatments. DNA Labs UAE is equipped with state-of-the-art facilities and staffed by expert professionals to ensure accurate and reliable test outcomes. Whether for preventive health measures, diagnostic purposes, or personalized medicine, the "Frozen-2 Test" represents a significant advancement in medical diagnostics, offering individuals a deeper understanding of their health and well-being.
The HbE Hemoglobin E Mutation Screening Prenatal Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at identifying the presence of the Hemoglobin E (HbE) mutation in unborn babies. This mutation leads to a variant form of hemoglobin, which can result in various health issues ranging from mild anemia to severe beta-thalassemia when combined with other hemoglobin mutations. The test is particularly crucial for expectant parents with a family history of hemoglobin disorders or those belonging to regions where these mutations are prevalent.
Conducted through a sample of amniotic fluid or chorionic villi obtained via amniocentesis or chorionic villus sampling (CVS), this prenatal screening plays a vital role in early detection, allowing for better preparedness and management of potential health conditions associated with the HbE mutation. Priced at 1200 AED, the test is a valuable investment for parents looking to ensure the well-being of their child, offering peace of mind and the possibility to consult with healthcare professionals for further steps and considerations based on the screening outcome.
